ESMO Patient Advocacy Track

Patient advocacy allows ESMO to support and promote equal access to optimal cancer treatment and care

Previously known as 'ESMO Patient Seminars', these meetings fulfill one of ESMO's most important objectives – to disseminate knowledge to advocacy groups, cancer patient associations, caregivers, and the public.

Patient Advocates play a crucial role in supporting and informing Cancer patients and caregivers and in providing valuable input into healthcare decision-making processes. In this setting, education of patient advocates becomes critical to both ensure that patients are provided with accurate information and that their input into healthcare decision-making processes is relevant. 

Since ESMO2016, the ESMO Patient Advocacy Track has been fully integrated in the Congress programme, enabling patient advocates to attend the scientific sessions that are relevant to them as well as the patient advocacy sessions. 

You can connect to the community joining the  ESMO Patient Advocates Facebook Group.

ESMO 2019 Patient Advocacy Track

27 September - 1 October 2019, Barcelona, Spain 

The 2019 Patient Advocates Track offered great educational sessions along with many opportunities to exchange best practices and network:

  • 7 sessions and 33 faculty members
  • Average of 350 attendees (with a few sessions attended by 800 delegates)
  • More than 150 travel grants distributed
  • 40 different countries represented, including Mexico, India, Canada and USA
  • 7 industry supporters via educational grants

ESMO 2019 Patient Advocacy Track webcasts

ESMO 2018 Patient Advocacy Track

19-23 October 2018, Munich, Germany

ESMO 2018 Patient Advocacy Track has been very successful:

  • 8 sessions and 33 faculty members
  • Average of 260 attendees (with a few sessions resulting in overflow rooms)
  • More than 160 travel grants distributed
  • 38 different countries represented, including Canada, China, India, USA
  • 8 industry supporters via educational grants

ESMO 2018 Patient Advocacy Track webcasts

ESMO 2017 Patient Advocacy Track

8-12 September 2017, Madrid, Spain

ESMO 2017 Patient Advocacy Track registered the largest participation ever!

  • 8 sessions and 35 faculty members
  • Average of 250 attendees with peaks of over 1000 attendees for IO toxicities and 600 for PA reported outcomes
  • 180 travel grants distributed
  • 35 different countries represented, including USA, Brazil, India, Australia and Japan
  • 7 industry supporters via educational grants

ESMO 2017 Patient Advocacy Track webcasts

ESMO 2016 Patient Advocacy Track

7-11 October 2016, Copenhagen, Denmark

The ESMO 2016 Patient Advocacy Track  had a new format, with advocacy-specific sessions taking place on the Friday (in parallel to industry-sponsored satellite symposia) and during lunch and early evening for the remainder of the congress.

This allowed patient advocates to attend sessions of interest to the advocacy community from other tracks such as Public Health and Health Economics, Supportive Care and Immunotherapy.

ESMO 2016 Patient Advocacy Track webcasts

ESMO 2014 Patient Advocacy Track

27-28 September 2014, Madrid, Spain

For the first time at the ESMO 2014 Congress an entire track was dedicated to cancer patient advocates, representative of cancer leagues, healthcare professionals and industry representatives.

The event provided European patient organisations and bodies involved in patient care with an excellent networking opportunity and the possibility to discuss vital issues and challenges faced by cancer patients

The ESMO 2014 Patient Advocacy Track focused on Cancer Research, Treatment and Living, Capacity Building and Patient Adovacy. The track closed with a tribute to Selma Schimmel Founder of Vital Options® International, who passed away in May 2014 from a complication of ovarian cancer.

ESMO 2014 Patient Advocacy Track webcasts

9th ESMO Patient Seminar

Held in Vienna, Austria, on Saturday 29 and Sunday 30 September 2012

8th ESMO Patient Seminar

Held in Milan, Italy, on Saturday 9 and Sunday 10 October 2010